The Ozempic lawsuit Morgan and Morgan update for 2026 is one of the most searched legal topics in America right now. Tens of thousands of people who took Ozempic, Wegovy, or other semaglutide drugs are now pursuing legal claims after suffering serious and sometimes permanent stomach injuries.
Morgan and Morgan, one of the largest personal injury firms in the United States, is actively representing Ozempic claimants in the ongoing Multi-District Litigation. The MDL docket has grown to include thousands of cases, and 2026 is shaping up to be the most consequential year in this litigation so far.
This article covers everything you need to know. You will learn who qualifies, what injuries are covered, how much settlements could be worth, and exactly how to get your case started.
One striking fact: some legal analysts estimate the total Ozempic litigation could eventually result in settlements exceeding $1 billion across all plaintiffs, putting it in the same tier as major pharmaceutical mass torts from previous decades.
Ozempic Lawsuit Morgan and Morgan Update: Where Things Stand Right Now
The Ozempic lawsuit Morgan and Morgan update for 2026 shows a litigation that has moved from early filing stages into active pre-trial maneuvering. Morgan and Morgan began accepting Ozempic clients in 2023 and has continued building its case inventory through 2024 and into 2026.
The firm has publicly stated it is investigating claims from people who experienced gastroparesis, intestinal obstruction, and other serious gastrointestinal injuries after using GLP-1 receptor agonist drugs like Ozempic and Wegovy.
As of early 2026, the MDL in the Eastern District of Pennsylvania contains several thousand individual cases. Morgan and Morgan represents a significant portion of those plaintiffs.
| Update Category | 2026 Status |
|---|---|
| MDL Case Count | Several thousand active cases |
| MDL Court | Eastern District of Pennsylvania (MDL 3094) |
| Morgan and Morgan Involvement | Active plaintiffs’ counsel |
| Primary Injuries Alleged | Gastroparesis, intestinal obstruction |
| Defendant | Novo Nordisk (Ozempic, Wegovy) |
| General Trial Outlook | Bellwether trials anticipated in 2026 |
The litigation is not moving slowly. Courts have been pushing discovery deadlines, and plaintiffs’ attorneys are preparing medical expert testimony for bellwether proceedings.
Key point: Morgan and Morgan is among the firms driving this litigation forward, not sitting on the sidelines waiting for another firm to take the lead.
What Is the Morgan and Morgan Ozempic Lawsuit?
Morgan and Morgan’s Ozempic lawsuit is a personal injury mass tort claim filed against Novo Nordisk, the Danish pharmaceutical company that manufactures Ozempic and Wegovy. The central allegation is that Novo Nordisk knew or should have known about serious gastrointestinal risks and failed to adequately warn patients and doctors.
This is a product liability case rooted in the legal theory of failure to warn. Under that theory, a drug manufacturer can be held liable even if its product was FDA-approved, if the warning label did not adequately disclose known risks.
Morgan and Morgan files individual lawsuits on behalf of each client. These cases are then consolidated into the MDL for coordinated pretrial proceedings.
| Case Element | Detail |
|---|---|
| Type of Claim | Personal injury / product liability |
| Legal Theory | Failure to warn |
| Defendant | Novo Nordisk A/S |
| Drugs Involved | Ozempic, Wegovy, Rybelsus (semaglutide) |
| Filing Court | Eastern District of Pennsylvania |
| Morgan and Morgan Role | Plaintiffs’ counsel |
The firm’s scale gives it resources that smaller operations do not have. Morgan and Morgan employs more than 1,000 attorneys across the country and has the infrastructure to handle a high-volume pharmaceutical mass tort.
Ozempic Lawsuit Update 2026: What Has Changed This Year
The 2026 Ozempic lawsuit update reflects a litigation that is now entering its most critical phase. Discovery is ongoing, expert witnesses are being deposed, and the court is managing a growing docket with efficiency that suggests it is serious about moving toward trial.
In late 2024 and continuing into 2025, the FDA updated Ozempic’s warning label to include references to intestinal obstruction and ileus. That label update is significant because plaintiffs’ attorneys argue it confirms what Novo Nordisk should have disclosed years earlier.
By 2026, the legal debate has shifted. It is no longer about whether these injuries happen. It is about what Novo Nordisk knew and when.
Bold fact: The FDA label update strengthens failure-to-warn claims because it shows regulators eventually agreed the risk was real enough to disclose.
Key 2026 developments include:
- Continued deposition of Novo Nordisk executives and medical officers
- Expert witness battles over causation and medical evidence
- Growing plaintiff count as more injured users come forward
- Settlement discussions beginning in the background of MDL proceedings
- Bellwether trial scheduling becoming a central court focus
This is the phase of a mass tort where things get real. Think of it like a long chess match that has been quietly building for two years. The big moves are starting now.
Ozempic MDL 2026: Understanding the Multi-District Litigation
The Ozempic MDL 2026 refers to In Re: Ozempic (Semaglutide) Products Liability Litigation, MDL No. 3094, centralized in the Eastern District of Pennsylvania. MDL stands for Multi-District Litigation, which is a federal court process that consolidates similar cases from across the country into one court for pretrial purposes.
MDL is not the same as a class action. Each plaintiff in an MDL keeps their own individual lawsuit. They benefit from shared discovery, shared expert witnesses, and coordinated motions, but their case is separate.
This matters because your compensation in an MDL depends on your specific injuries, your medical records, and your individual circumstances.
| MDL Feature | What It Means for You |
|---|---|
| Consolidated pretrial | Your case shares discovery costs with thousands of others |
| Individual lawsuits | Your payout is based on your injuries, not a shared pool |
| Bellwether trials | Test cases that signal how juries might value claims |
| Settlement negotiations | Often happen after bellwether results are in |
| MDL Judge | Oversees scheduling, motions, and case management |
The Eastern District of Pennsylvania MDL is one of the most active pharmaceutical MDLs in the country right now. Courts in that district have experience managing complex drug litigation, which is an advantage for plaintiffs.
Key Takeaway: The Ozempic MDL 2026 is a federal consolidation of thousands of individual lawsuits, and Morgan and Morgan is an active participant representing injured plaintiffs in those proceedings.
Ozempic Bellwether Trial 2026: What to Expect
Ozempic bellwether trials in 2026 are among the most important events in this entire litigation. A bellwether trial is a test case that goes before a jury first, before the broader group of cases settles. The results tell both sides how juries will likely react to the evidence.
If a jury awards a plaintiff $10 million in a bellwether trial, Novo Nordisk’s settlement math changes dramatically. If a jury finds for the defense, plaintiffs may accept lower offers.
Bellwether trials are the pressure point in pharmaceutical mass torts. They are what finally push drug companies toward negotiating serious settlement numbers.
As of 2026, the court has been working through the process of selecting bellwether plaintiffs. These are typically chosen to represent a cross-section of the broader plaintiff pool in terms of injury type, severity, and state of residence.
| Bellwether Process Stage | Expected Timing |
|---|---|
| Case selection for bellwether pool | Late 2025 to early 2026 |
| Discovery on bellwether cases | 2026 |
| Expert witness Daubert hearings | 2026 |
| First bellwether trial | Late 2026 or early 2027 |
| Post-trial settlement discussions | Following first verdict |
The outcome of the first bellwether trial will likely be the single biggest event in the Ozempic litigation in the near term. It will set the tone for everything that comes after.
Who Qualifies for the Ozempic Lawsuit?
You may qualify for the Ozempic lawsuit if you took Ozempic, Wegovy, Rybelsus, or another semaglutide drug and then suffered a serious gastrointestinal injury. Qualification is not automatic, and each case is reviewed on its own facts.
The basic eligibility framework used by plaintiffs’ firms, including Morgan and Morgan, focuses on three things: what drug you took, what injury you suffered, and how severe that injury was.
People who took the drug for weight loss or diabetes management and then experienced gastroparesis, intestinal obstruction, or ileus are the strongest candidates.
| Eligibility Factor | Qualifying Detail |
|---|---|
| Drug taken | Ozempic, Wegovy, Rybelsus, or generic semaglutide |
| Injury suffered | Gastroparesis, intestinal obstruction, ileus |
| Hospitalization | Often required; at least documented medical treatment |
| Prescription required | Yes, must have a documented prescription |
| Injury onset | During or shortly after taking the drug |
| Medical records | Must be obtainable |
People who experienced mild nausea or temporary stomach discomfort typically do not qualify. The injuries at the center of this litigation are serious, often requiring hospitalization, feeding tubes, or surgery.
Ozempic Eligibility Requirements: The Specific Details
Ozempic lawsuit eligibility requirements go beyond just “I took the drug and got sick.” Law firms have specific intake criteria they use to filter cases because not every claim has merit in mass tort litigation.
Morgan and Morgan and other firms generally look for claimants who meet all of the following criteria.
Core eligibility checklist:
- Took a GLP-1 receptor agonist (Ozempic, Wegovy, Mounjaro, Trulicity, Rybelsus) for at least 30 days
- Received a formal medical diagnosis of gastroparesis, intestinal obstruction, or ileus
- Sought medical treatment for the condition (ER visit, hospitalization, or specialist care)
- Injury occurred during or after semaglutide use
- Medical records documenting both the prescription and the diagnosis exist
Cases involving prior gastroparesis diagnosis before starting the drug face more scrutiny. Pre-existing conditions do not automatically disqualify you, but they complicate the causation argument.
| Requirement | Qualifies | May Not Qualify |
|---|---|---|
| Drug duration | 30 or more days | One-time dose |
| Diagnosis | Formal medical diagnosis | Self-diagnosed symptoms |
| Injury severity | Hospitalization or specialist treatment | Mild nausea only |
| Medical records | Available | Completely unavailable |
| Pre-existing condition | None related | Prior gastroparesis |
Getting an early case evaluation is the fastest way to find out where you stand. Morgan and Morgan offers free case evaluations.
Key Takeaway: Eligibility for the Ozempic lawsuit requires a formal medical diagnosis of a serious GI injury tied to documented GLP-1 drug use. The stronger your medical records, the stronger your case.
Ozempic Gastroparesis Lawsuit: The Most Common Injury Claim
The Ozempic gastroparesis lawsuit is the dominant injury category within the entire Ozempic mass tort. Gastroparesis literally means stomach paralysis. The stomach stops emptying normally, causing severe nausea, vomiting, bloating, and malnutrition.
GLP-1 drugs like Ozempic slow gastric emptying as part of how they work. The concern is that in some users, this mechanism triggers a permanent or chronic form of gastroparesis that does not resolve after stopping the drug.
Plaintiffs in gastroparesis cases argue that Novo Nordisk did not adequately warn users or prescribers that the drug could cause lasting stomach paralysis.
Key medical fact: Gastroparesis has no reliable cure. Many patients manage symptoms for life through dietary restrictions, medication, or feeding tubes.
This long-term, life-altering nature of gastroparesis is what makes these cases high-value in litigation. Juries and insurers both take chronic, debilitating conditions seriously when calculating damages.
| Gastroparesis Claim Factor | Detail |
|---|---|
| Mechanism | Drug slows gastric emptying, potentially permanently |
| Diagnosis tool | Gastric emptying study (nuclear scan) |
| Common symptoms | Severe nausea, vomiting, inability to eat, bloating |
| Severity range | Mild to life-threatening |
| Treatment | Dietary changes, medication, feeding tubes |
| Legal theory | Failure to warn of permanent risk |
If you were diagnosed with gastroparesis after taking Ozempic, this is among the strongest categories of claims in the current litigation.
Ozempic Intestinal Obstruction Lawsuit: The Second Major Injury Category
Ozempic intestinal obstruction lawsuits cover a different but equally serious injury. Intestinal obstruction occurs when the bowels stop moving food and waste through the digestive system. It can become life-threatening without emergency treatment.
The FDA updated Ozempic’s prescribing information in 2024 to include intestinal obstruction as a known risk. Before that update, many prescribers and patients had no idea this was a possibility.
That gap between what Novo Nordisk knew and what it disclosed is at the heart of intestinal obstruction claims.
- Cases often involve emergency room visits and emergency surgery
- Some plaintiffs required bowel resection (surgical removal of part of the intestine)
- Long-term digestive function can be permanently affected
- Post-surgical complications add to damages calculations
| Obstruction Claim Factor | Detail |
|---|---|
| Medical term | Intestinal obstruction or ileus |
| FDA acknowledgment | Warning label updated in 2024 |
| Typical treatment | Hospitalization, bowel rest, sometimes surgery |
| Legal strength | High, due to FDA label timing vs. known risk |
| Key evidence | ER records, surgical reports, imaging scans |
Intestinal obstruction cases can carry higher individual claim values than gastroparesis cases when they involve surgery, because the documented harm is more immediate and severe.
Ozempic Side Effects Lawsuit: What Conditions Are Covered
The Ozempic side effects lawsuit covers a broader category than just gastroparesis and intestinal obstruction. While those two are the primary injuries driving the mass tort, other serious conditions may also be compensable depending on how the litigation evolves.
Current side effects being investigated in litigation include:
- Gastroparesis (stomach paralysis)
- Intestinal obstruction
- Ileus (temporary bowel paralysis)
- Severe gastroesophageal reflux disease (GERD) requiring surgery
- Aspiration pneumonia related to delayed gastric emptying
- Malnutrition and dehydration requiring hospitalization
Not all of these have the same legal footing right now. Gastroparesis and intestinal obstruction are the strongest because they have the most medical literature and the clearest connection to GLP-1 drug mechanisms.
| Side Effect | Current Legal Status |
|---|---|
| Gastroparesis | Primary injury, strong claims |
| Intestinal obstruction | Primary injury, strong claims |
| Ileus | Related, included in many MDL cases |
| Aspiration pneumonia | Secondary, under investigation |
| Severe GERD | Some claims pending, less established |
| Malnutrition | Often part of gastroparesis claim, not standalone |
If you experienced a severe side effect not on this list, a case evaluation can still determine if there is a viable claim.
Key Takeaway: The Ozempic side effects lawsuit primarily covers gastroparesis and intestinal obstruction, but other serious GI injuries may qualify depending on medical documentation and how the case law develops in 2026.
Novo Nordisk Ozempic Lawsuit: Who Is Being Sued
The Novo Nordisk Ozempic lawsuit targets the Danish pharmaceutical giant that manufactures and markets Ozempic and Wegovy in the United States. Novo Nordisk is one of the world’s largest pharmaceutical companies, with annual revenues exceeding $30 billion.
Plaintiffs allege Novo Nordisk knew about serious gastrointestinal risks from early clinical trial data and post-market surveillance but did not update its warning labels in a timely or adequate manner. The core legal theory is failure to warn, supplemented in some cases by design defect and negligence claims.
Novo Nordisk has denied wrongdoing and defended its drug as safe and effective when used as prescribed.
| Defendant Profile | Detail |
|---|---|
| Company | Novo Nordisk A/S |
| Headquarters | Bagsvaerd, Denmark |
| Products at issue | Ozempic, Wegovy, Rybelsus |
| Annual revenue | Approximately $30 billion plus |
| Legal position | Denying liability, defending claims |
| Settlement history | No global settlement as of early 2026 |
One context point worth keeping in mind: Novo Nordisk has enormous financial resources to fight this litigation for years. That is precisely why firms like Morgan and Morgan, which can match those resources, matter to individual plaintiffs.
Ozempic Class Action vs Mass Tort: What Is the Difference
The Ozempic lawsuit is a mass tort, not a traditional class action, and that distinction matters enormously for your payout. In a class action, all plaintiffs share one settlement pool divided evenly or by a formula. In a mass tort, each plaintiff has an individual case with individual damages.
This means an Ozempic plaintiff with a severe gastroparesis case requiring surgery and long-term feeding tube use will receive far more compensation than someone with a milder documented injury, if the litigation settles.
Think of it this way: a class action is like splitting a pizza equally. A mass tort is like ordering your own meal based on what you actually need.
| Feature | Class Action | Mass Tort (Ozempic) |
|---|---|---|
| Your case | Shared | Individual |
| Your payout | Equal share | Based on your injuries |
| Legal process | One case | Thousands of individual cases |
| MDL role | Not applicable | Pre-trial coordination tool |
| Settlement amount | Fixed pool divided | Negotiated per plaintiff |
| Opt-out option | Often yes | Individual decision |
The mass tort structure is actually better for seriously injured plaintiffs because your compensation reflects the real impact of your injury on your life.
Key Takeaway: The Ozempic litigation is a mass tort handled through an MDL, meaning your settlement is based on your individual injuries. Seriously harmed plaintiffs stand to receive significantly more than in a traditional class action.
Ozempic Lawsuit Settlement Amount: What Could Cases Be Worth
No official Ozempic lawsuit settlement has been reached as of early 2026, but legal analysts and plaintiffs’ attorneys are discussing ranges based on comparable pharmaceutical mass tort outcomes. Settlement amounts in pharmaceutical injury cases depend on several factors specific to each claimant.
Factors that affect individual Ozempic settlement amounts:
- Severity of diagnosis (gastroparesis vs. intestinal obstruction requiring surgery)
- Number of hospitalizations and their duration
- Ongoing medical treatment needs
- Lost income and lost earning capacity
- Pain and suffering over time
- Whether the claimant has passed away (wrongful death claim)
| Injury Category | Estimated Settlement Range |
|---|---|
| Mild to moderate gastroparesis | $100,000 to $500,000 |
| Severe gastroparesis (chronic, ongoing) | $500,000 to $2,000,000 |
| Intestinal obstruction requiring surgery | $300,000 to $1,500,000 |
| Wrongful death | $1,000,000 to $5,000,000+ |
These are estimates based on similar drug litigation and are not guarantees. Actual amounts will be shaped by bellwether trial outcomes and global settlement negotiations that are expected to intensify in late 2026.
Bellwether verdicts often function as anchors for settlement math. A $5 million jury verdict in a bellwether case tends to push the average settlement value upward across the entire MDL.
Ozempic Lawsuit Payout Per Person: Realistic Expectations
The Ozempic lawsuit payout per person will vary widely based on individual case facts. That is the honest answer, and any site giving you a single fixed number is misleading you. However, there are ways to estimate where your case might fall.
Cases with the highest individual payout potential share these traits:
- Formal diagnosis of gastroparesis confirmed by a gastric emptying study
- Multiple hospitalizations or a prolonged hospital stay
- Surgical intervention required
- Ongoing medical treatment with documented costs
- Clear evidence of lost wages due to the condition
- Strong pre- and post-drug medical record contrast
| Payout Driver | Impact on Claim Value |
|---|---|
| Documented hospitalization | High positive impact |
| Surgical intervention | High positive impact |
| Formal medical diagnosis | Required for any claim |
| Ongoing treatment costs | Adds to economic damages |
| Lost income documentation | Adds to economic damages |
| Duration of injury | Longer injury means higher pain and suffering |
Punitive damages are possible if plaintiffs prove Novo Nordisk acted with reckless disregard for consumer safety. In pharmaceutical cases, punitive damages can multiply the base award significantly.
No payout is guaranteed. But understanding these drivers helps you see why documentation matters so much right now.
Ozempic Lawsuit Compensation: What You Can Claim
Ozempic lawsuit compensation falls into two main categories: economic damages and non-economic damages. Both can be substantial when the injury is severe and well-documented.
Economic damages are the calculable financial losses from your injury:
- Medical bills (past and future)
- Prescription costs
- Surgery and hospitalization costs
- Lost wages and income
- Future lost earning capacity
- Home care or nursing assistance costs
Non-economic damages cover the human cost of the injury:
- Pain and suffering
- Emotional distress
- Loss of enjoyment of life
- Loss of consortium (impact on spousal relationship)
| Damage Type | Examples |
|---|---|
| Medical bills | ER visits, surgeries, specialist fees |
| Future medical | Ongoing gastroparesis management |
| Lost wages | Missed work during illness |
| Pain and suffering | Chronic nausea, inability to eat normally |
| Emotional distress | Anxiety, depression tied to chronic illness |
| Punitive damages | If Novo Nordisk’s conduct was reckless |
Wrongful death claims, filed by surviving family members, can include all of the above plus funeral costs and loss of companionship.
The more thorough your medical documentation, the clearer the picture of your economic damages. That documentation becomes the foundation of your compensation calculation.
Ozempic Lawsuit Statute of Limitations: Do Not Miss the Deadline
The Ozempic lawsuit statute of limitations is one of the most time-sensitive elements of your case, and missing it means permanently losing your right to sue. Every state has its own statute of limitations for personal injury claims, and pharmaceutical cases follow those state-specific rules.
Most states set a statute of limitations of two to three years from the date of injury or the date you discovered your injury was linked to the drug. The discovery rule is important here: if you did not connect your gastroparesis to Ozempic until 2024, your clock may have started then, not when you first got sick.
| State | Typical Statute of Limitations |
|---|---|
| California | 2 years |
| Texas | 2 years |
| Florida | 2 years |
| New York | 3 years |
| Pennsylvania | 2 years |
| Illinois | 2 years |
These are general guidelines. Your attorney will determine the exact deadline for your state and circumstances.
Warning: Waiting until you are “sure” the lawsuit will succeed is a strategy that often results in missing your deadline entirely. Filing preserves your rights. Not filing forfeits them.
If you are anywhere near the two-year mark from your injury or diagnosis, do not delay.
How to File an Ozempic Lawsuit: Step by Step
Filing an Ozempic lawsuit is simpler than most people expect. You do not pay anything upfront. Plaintiffs’ firms like Morgan and Morgan take these cases on contingency, meaning they only get paid if you win.
Step-by-step process:
- Contact a law firm (free case evaluation)
- Provide basic information about your drug use and injury
- Firm reviews your case for eligibility
- Sign a retainer agreement if accepted
- Firm gathers your medical records
- Your individual lawsuit is filed in federal court
- Your case is transferred into the MDL
- You participate in discovery (mostly handled by your attorney)
- Await bellwether trial outcomes and potential settlement
| Step | What Happens |
|---|---|
| Case evaluation | Free, no commitment |
| Medical records request | Handled by your attorney |
| Case filing | Your attorney files the complaint |
| MDL transfer | Your case joins the consolidated litigation |
| Settlement or trial | Resolved individually based on your facts |
You do not need to prepare anything before your first call. Just know what drug you took, when you took it, and what medical treatment you received. Your attorney handles the rest.
Key Takeaway: Filing an Ozempic lawsuit costs nothing upfront. You start with a free case evaluation, your attorney handles all filings and medical records, and you only pay if your case resolves successfully.
Morgan and Morgan Ozempic Case Evaluation: What to Expect
A Morgan and Morgan Ozempic case evaluation is a free, no-obligation conversation where an intake specialist or attorney reviews your situation to determine whether you have a qualifying claim. The process is straightforward and can typically be completed in under an hour.
What you will be asked during evaluation:
- Which drug did you take (Ozempic, Wegovy, Mounjaro, etc.)
- How long did you take it
- What injuries or symptoms did you experience
- Did you seek medical treatment
- Do you have a formal diagnosis
- When were you first diagnosed
| Evaluation Stage | What to Expect |
|---|---|
| Initial contact | Phone or online form |
| Case review | 30 to 60 minutes |
| Records request | If accepted, firm requests your medical records |
| Decision | Firm tells you if your case qualifies |
| Retainer | Signed only if you proceed |
| No upfront cost | Morgan and Morgan works on contingency |
Morgan and Morgan’s size means it has resources to take cases that smaller firms cannot afford to invest in. This matters in pharmaceutical mass torts where litigation costs easily reach six figures per case before any trial begins.
If your case is not accepted, you will still have a clearer picture of your options. And if it is, you will have one of the largest plaintiff-side firms in the country working for you.
Frequently Asked Questions
What is the current status of the Ozempic lawsuit with Morgan and Morgan in 2026?
Morgan and Morgan is actively representing Ozempic claimants within MDL 3094 in the Eastern District of Pennsylvania.
The litigation is in active pretrial proceedings, with bellwether trial selection underway and expert witness depositions continuing through 2026.
No global settlement has been reached, but settlement discussions are expected to intensify following the first bellwether trial result.
How much money can I get from an Ozempic lawsuit settlement?
Settlement amounts vary by injury severity, with estimates ranging from $100,000 for mild cases to over $2 million for severe, chronic gastroparesis or surgical intestinal obstruction cases.
No official settlement has been announced as of early 2026, so these are projections based on comparable pharmaceutical mass tort outcomes.
Final amounts will be shaped by bellwether trial verdicts and negotiations between Novo Nordisk and plaintiffs’ counsel.
How do I know if I qualify for the Ozempic lawsuit?
You likely qualify if you took Ozempic, Wegovy, or another semaglutide drug and were diagnosed with gastroparesis, intestinal obstruction, or ileus.
You need a formal medical diagnosis and documented medical treatment such as hospitalization or specialist care.
A free case evaluation with Morgan and Morgan or another plaintiffs’ firm is the fastest way to confirm eligibility.
What is the statute of limitations for filing an Ozempic lawsuit?
Most states allow two to three years from the date of injury or the date you discovered your injury was linked to the drug.
The discovery rule may extend your deadline if you only recently connected your condition to Ozempic.
Because deadlines vary by state and individual circumstances, do not wait to find out how much time you have left.
Is the Ozempic lawsuit a class action or a mass tort?
The Ozempic lawsuit is a mass tort, not a class action.
Each plaintiff has an individual case, and your compensation is based on your specific injuries rather than a shared settlement pool.
This structure benefits seriously injured plaintiffs because payouts reflect the true severity of each person’s harm.
What You Should Do Right Now
The Ozempic litigation is past the question of whether these cases have merit. Courts have accepted them. The MDL is active. Bellwether trials are being scheduled. The real question in 2026 is whether you file in time to be included.
If you took Ozempic, Wegovy, or another GLP-1 drug and suffered a diagnosed stomach condition, your window to act is open right now. The statute of limitations is running.
Reach out for a free case evaluation. Your medical records do not need to be in hand before you make that call. You just need to start the conversation and let an attorney determine whether your situation qualifies.
